ClinicalTrials.gg
CompletedNCT02096549Updated Jan 30, 2024Results posted

Validity of Bispectral Index Monitoring During Deep Sedation

An observational study in Cerebral Palsy, sponsored by Yeungnam University College of Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 3 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-01-30.

Sponsored by Yeungnam University College of Medicine · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
3 Years to 18 Years
Sex
All
01

Study summary

During Intramuscular botulinum toxin injections for children with cerebral palsy, immobility is essential to inject botulinum toxin to the right muscle. Because children with cerebral palsy are generally unable to control their movement, deep sedation is required during this painful procedure.

Short-acting drugs such as propofol and remifentanil are widely used for pediatric anesthesia and sedation but still have possibility of over-sedation and associated complications due to their rather narrow therapeutic window. Therefore, objective scoring system to assess the level of sedation to provide an effective and safe sedation in children. Bispectral index (BIS) monitoring,an objective guidance of sedation might be helpful.

The present study is to investigate the validity of the BIS monitoring during deep sedation of children with cerebral palsy for injection of botulinum toxin.

Read the detailed description

Intramuscular botulinum toxin injections for children with cerebral palsy have been extensively performed to relive spasticity and improve rehabilitation. During procedure immobility is essential to inject botulinum toxin to the right muscle for optimal effect. Because children with cerebral palsy are generally unable to control their movement, deep sedation is required during this painful procedure.

Short-acting drugs with rapid, predictable onset and offset of action, such as propofol and remifentanil, facilitate infusion rate adjustments and rapid recovery. However, there is always the possibility of over-sedation, hypotension and respiratory depression due to their rather narrow therapeutic window.

Several clinical sedation scales have been used to provide an effective and safe sedation in children. Because clinical scoring depends on patient response to verbal or physical stimulation, it is difficult to assess the level of sedatin in patients with deep sedation during delicate phase of the procedure. Bispectral index (BIS) monitoring,an objective guidance of sedation might be helpful. Although BIS scores in children with conscious and deep sedation were reported to correlate with clinical sedation scales, the validity during painful procedure in children with cerebral palsy was not investigated yet.

The present study is to investigate the validity of the BIS monitoring and its correlation to University of Michigan sedation scale during deep sedation of children with cerebral palsy for injection of botulinum toxin.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • cerebral palsy
  • Botulinum toxin
  • Propofol
  • Deep sedation
  • Bispectral index monitor
03

In context

Cerebral Palsy

1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.

This study's enrollment of 20 is below the median of 63 across 472 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Yeungnam University College of Medicine is the lead sponsor of 32 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

primary care clinic (rehabilitation)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (ASA) physical status I-II healthy children Ages Eligible for study: 3 to 18 years scheduled for injection of botulinum toxin under deep sedation

Exclusion criteria

Exclusion Criteria:

  • Unstable cardiac disease Recent (\< 8 week) pneumonia, bronchitis, asthma attack, respiratory infection Craniofacial defect History of a difficult airway management Hypotonia and lack of head control Tremors
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The Correlation Between the Paired BIS Value Categories and Clinical Sedation Scores

    Two independent investigators assessed the level of sedation using the Universtiy of Michigan sedation scale (UMSS) and modified observer's assessment of alertness and sedation (MOAAS) scales every 1 min during the induction of sedation and every 3 min during the maintenance of sedation. The BIS values at each UMSS and MOAAS score were collected. The correlation between the BIS score and UMSS score, and BIS score and MOAAS score was analyzed using the Spearman rank correlation test. The correlation coefficient is expressed as an r-value, and this value is expressed as a single value, not as a range with the lowest and highest values. The higher the value, the better the outcome.

    Time frame: From induction of sedation to completion of procedure(botulinum toxin injection)

07

Results

Posted Jan 30, 2024
Limitations and caveats
This study has some limitations. We couldn't identify the age-related correlations among the CP children undergoing botulinum toxin injection and we did not know the correlation with BIS scores and UMSS and MOAAS scores according to sex.

Participant flow

This study was conducted at Yeungnam Univerisity Hospital in South korea from March 2014 to April 2017. Twenty children with spastic CP, with an American Society of Anesthesiologists physical status of 1 and 2, aged between 3 and 18 years, who were scheduled for a botulinum toxin injection under deep sedation, were enrolled.

Participant flow — Overall Study
MilestoneChildren With Spastic Cerebral Palsy
Started20
Completed20
Not completed0

Outcome measures

PrimaryThe Correlation Between the Paired BIS Value Categories and Clinical Sedation Scores

Two independent investigators assessed the level of sedation using the Universtiy of Michigan sedation scale (UMSS) and modified observer's assessment of alertness and sedation (MOAAS) scales every 1 min during the induction of sedation and every 3 min during the maintenance of sedation. The BIS values at each UMSS and MOAAS score were collected. The correlation between the BIS score and UMSS score, and BIS score and MOAAS score was analyzed using the Spearman rank correlation test. The correlation coefficient is expressed as an r-value, and this value is expressed as a single value, not as a range with the lowest and highest values. The higher the value, the better the outcome.

Time frame:
From induction of sedation to completion of procedure(botulinum toxin injection)
Reported as:
Number · correlation coefficient
The Correlation Between the Paired BIS Value Categories and Clinical Sedation Scores
correlation coefficientChildren With Spastic Cerebral Palsy
correlation of the UMSS score and BIS value0.917 (0.858 to 0.969)
Correlation for the MOAAS score and BIS value0.874 (0.808 to 0.940)

Adverse events

Collected over 24 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Validity of Bispectral Index Monitoring0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

22 children with cerebral palsy

Age, Continuous
Age, Continuous(years)Spastic Cerebral Palsy
Mean10.5 ± 5.3
Sex: Female, Male
Sex: Female, Male(Participants)Spastic Cerebral Palsy
sex — Female7
sex — Male15
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Spastic Cerebral Palsy
Asian20
08

Study locations

1 site
  • Yeungnam University Hospital
    Daegu, 705-717, Korea, Republic of
09

References and documents

Publications

  • McDermott NB, VanSickle T, Motas D, Friesen RH. Validation of the bispectral index monitor during conscious and deep sedation in children. Anesth Analg. 2003 Jul;97(1):39-43, table of contents. doi: 10.1213/01.ane.0000067402.02136.a2. PubMed 12818940 ↗
  • Soudant DL, Staal HM, Witlox AM, Vles JS. Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit. Eur J Paediatr Neurol. 2013 Mar;17(2):219-20. doi: 10.1016/j.ejpn.2012.06.012. Epub 2012 Aug 4. No abstract available. PubMed 22871256 ↗
  • American Academy of Pediatrics; American Academy of Pediatric Dentistry; Cote CJ, Wilson S; Work Group on Sedation. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update. Paediatr Anaesth. 2008 Jan;18(1):9-10. doi: 10.1111/j.1460-9592.2007.02404.x. No abstract available. PubMed 18095958 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — no plan to share our data

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02096549
Lead sponsor
Yeungnam University College of Medicine
Responsible party
Sung Mee Jung (Associate professor in Anesthesiology and Pain Medicine, Yeungnam University College of Medicine) — Principal investigator
First posted
Mar 26, 2014
Start date
Mar 2014
Primary completion
Apr 30, 2017
Completion
Apr 30, 2017
Results posted
Jan 30, 2024
Last update
Jan 30, 2024

Study contacts

Duk Hee Lee, M.D.
study director · Yeungnam University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion